White Noise and Crying Duration After Invasive Procedures in Infants
The Effect of White Noise on Crying Duration After Invasive Procedures in Infants Aged 1-3 Months
1 other identifier
interventional
37
1 country
1
Brief Summary
The aim of this study is to evaluate the effect of white noise applied during invasive procedures (blood sampling or intravenous access) on pain and physical parameters in infants aged 1-3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2026
CompletedMarch 17, 2026
March 1, 2026
2 months
March 2, 2026
March 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Crying Duration
Immediately after each invasive procedure (0-5 minutes)
Study Arms (2)
White Noise Group
EXPERIMENTALNo White Noise Group
NO INTERVENTIONInterventions
Infants undergo routine invasive procedures while continuous white noise audio is played through speakers. Crying duration is measured immediately after each procedure to evaluate the effect of white noise on procedural distress.
Eligibility Criteria
You may qualify if:
- Infants aged 1-3 months
- Born at term (≥37 weeks gestational age)
- Admitted to the general pediatric ward
- Scheduled for routine invasive procedures such as venipuncture or intravenous line placement
You may not qualify if:
- Infants with congenital anomalies
- Infants with hearing impairments
- Infants with a history of analgesic or pain-relieving medication use prior to the invasive procedure
- Infants requiring intensive care unit (ICU) monitoring
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Basaksehir Cam ve Sakura City Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 2, 2026
First Posted
March 6, 2026
Study Start
January 1, 2026
Primary Completion
March 15, 2026
Study Completion
April 15, 2026
Last Updated
March 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share